|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
US20050227915A1
(en)
|
2001-05-02 |
2005-10-13 |
Steffan Joan S |
Methods and reagents for treating neurodegenerative diseases and motor deficit disorders
|
|
ES2310213T3
(es)
|
2001-05-02 |
2009-01-01 |
The Regents Of The University Of California |
Procedimiento para tratar trastornos neurodegenerativos, psiquiatricos y otros trastornos con inhibidores de desacetilasa.
|
|
US20040142859A1
(en)
|
2002-05-02 |
2004-07-22 |
Steffan Joan S. |
Method for treating neurodegenerative, psychiatric, and other disorders with deacetylase inhibitors
|
|
WO2003032921A2
(en)
|
2001-10-16 |
2003-04-24 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
NZ550185A
(en)
|
2002-03-04 |
2008-10-31 |
Merck Hdac Res Llc |
Methods of inducing terminal differentiation Methods of inducing terminal differentiation
|
|
WO2003080864A1
(fr)
|
2002-03-26 |
2003-10-02 |
Exhonit Therapeutics Sa |
Histone deacetylase: nouvelle cible moleculaire de la neurotoxicite
|
|
AU2003226014A1
(en)
|
2002-03-28 |
2003-10-13 |
Brigham And Women's Hospital, Inc. |
Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
|
|
ITMI20040876A1
(it)
|
2004-04-30 |
2004-07-30 |
Univ Degli Studi Milano |
Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
|
|
US20060018921A1
(en)
|
2004-07-16 |
2006-01-26 |
Baylor College Of Medicine |
Histone deacetylase inhibitors and cognitive applications
|
|
GT200500321A
(es)
|
2004-11-09 |
2006-09-04 |
|
Compuestos y composiciones como inhibidores de proteina kinase.
|
|
CN101056632B
(zh)
*
|
2004-11-09 |
2011-12-07 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
|
US20060135612A1
(en)
|
2004-12-17 |
2006-06-22 |
U.S. Department Of Veterans Affairs |
Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
CA2616537A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
US20070078083A1
(en)
|
2005-09-07 |
2007-04-05 |
Braincells, Inc. |
MODULATION OF NEUORGENESIS BY HDac INHIBITION
|
|
WO2007049262A1
(en)
|
2005-10-27 |
2007-05-03 |
Berand Limited |
Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
|
|
US8026260B2
(en)
|
2005-11-03 |
2011-09-27 |
Merck Sharp & Dohme Corp. |
Histone deacetylase inhibitors with aryl-pyrazolyl-motifs
|
|
US20070207950A1
(en)
|
2005-12-21 |
2007-09-06 |
Duke University |
Methods and compositions for regulating HDAC6 activity
|
|
GB0612273D0
(en)
|
2006-06-21 |
2006-08-02 |
Friedrich Miescher Inst For Bi |
Prevention of muscle atrophy
|
|
US8088951B2
(en)
|
2006-11-30 |
2012-01-03 |
Massachusetts Institute Of Technology |
Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
|
|
WO2008073733A1
(en)
|
2006-12-08 |
2008-06-19 |
Kalypsys, Inc. |
Salts of inhibitors of histone deacetylase for the treatment of disease
|
|
MX2009006327A
(es)
|
2006-12-15 |
2009-06-23 |
Novartis Ag |
Compuestos heterociclicos y metodos de uso de los mismos.
|
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
|
AU2008269154B2
(en)
|
2007-06-27 |
2014-06-12 |
Merck Sharp & Dohme Llc |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
WO2009027349A2
(en)
|
2007-08-24 |
2009-03-05 |
Oryzon Genomics Sa |
Treatment and prevention of neurodegenerative diseases
|
|
US20090136461A1
(en)
|
2007-11-28 |
2009-05-28 |
Moon Suk Kim |
Neuronal differentiation method of adult stem cells using small molecules
|
|
AU2013203735A1
(en)
*
|
2007-12-04 |
2013-05-02 |
F. Hoffmann-La Roche Ag |
Isoxazolo-pyridine derivatives
|
|
RU2012131164A
(ru)
|
2009-12-22 |
2014-01-27 |
Селджин Корпорейшн |
(метилсульфонил)этил-бензол-изоиндолиновые производные и их терапевтическое применение
|
|
WO2011088192A1
(en)
|
2010-01-13 |
2011-07-21 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
KR101781663B1
(ko)
|
2010-01-13 |
2017-09-25 |
템페로 파마슈티칼즈, 인크. |
히스톤 데아세틸라제 효소를 억제하기 위한 화합물 및 이를 제조하는 방법
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
ES2647368T3
(es)
|
2010-10-08 |
2017-12-21 |
Vib Vzw |
Inhibidores de HDAC para tratar la enfermedad de Charcot-Marie-Tooth
|
|
US20130203735A1
(en)
|
2010-10-28 |
2013-08-08 |
John T. Sisko |
Caprolactam mglur5 receptor modulators
|
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
JP6250403B2
(ja)
|
2011-02-28 |
2017-12-20 |
バイオマリン ファーマシューティカル インク |
ヒストン脱アセチル化酵素阻害剤
|
|
EP2701699B1
(en)
|
2011-04-28 |
2019-10-16 |
The Broad Institute, Inc. |
Inhibitors of histone deacetylase
|
|
US20140235649A1
(en)
|
2011-05-24 |
2014-08-21 |
Lixte Biotechnology, Inc. |
Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
|
|
WO2013006408A1
(en)
|
2011-07-01 |
2013-01-10 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
CN103764635B
(zh)
|
2011-07-08 |
2016-01-20 |
诺华股份有限公司 |
新的三氟甲基-噁二唑衍生物及其在疾病治疗中的用途
|
|
WO2013009827A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009810A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009830A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
JP6169076B2
(ja)
|
2011-07-20 |
2017-07-26 |
ザ ジェネラル ホスピタル コーポレイション |
骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤
|
|
WO2013066839A2
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066833A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods to inhibit histone deacetylase (hdac) enzymes
|
|
WO2013066838A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066831A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066835A2
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
EP2785713B1
(en)
|
2011-11-28 |
2016-09-07 |
Novartis AG |
Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
|
|
US9480673B2
(en)
|
2012-03-29 |
2016-11-01 |
The Regents Of The University Of Colorado, A Body Corporate |
Composition and method for treating neurodegenerative disease
|
|
EP2841067A4
(en)
|
2012-04-25 |
2016-04-13 |
Univ California |
MEDICINAL SCREENING PLATFORM FOR THE RETT SYNDROME
|
|
WO2014006114A1
(en)
|
2012-07-05 |
2014-01-09 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
New treatment for neurodegenerative diseases
|
|
CN104894060B
(zh)
|
2014-03-03 |
2018-11-06 |
中国科学院上海生命科学研究院 |
诱导体细胞转分化为神经干细胞的方法及其应用
|
|
MX2016011833A
(es)
|
2014-03-12 |
2017-03-29 |
Chong Kun Dang Pharmaceutical Corp |
Nuevos compuestos como inhibidores de histona desacetilasa 6 y composiciones farmaceuticas que los comprenden.
|
|
WO2016031815A1
(ja)
|
2014-08-26 |
2016-03-03 |
武田薬品工業株式会社 |
複素環化合物
|
|
JPWO2016039398A1
(ja)
|
2014-09-09 |
2017-06-15 |
国立大学法人大阪大学 |
含窒素複素環誘導体、神経保護剤及び癌治療用医薬組成物
|
|
WO2016126721A1
(en)
|
2015-02-02 |
2016-08-11 |
Forma Therapeutics, Inc. |
3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
|
|
CN107848695A
(zh)
*
|
2015-06-30 |
2018-03-27 |
Wm.雷格利 Jr.公司 |
用于糖果产品的包装和用于形成该包装的方法
|
|
EP3327019A4
(en)
|
2015-07-17 |
2019-04-03 |
Takeda Pharmaceutical Company Limited |
HETEROCYCLIC CONNECTION
|
|
CN108026088B
(zh)
*
|
2015-07-17 |
2021-02-12 |
武田药品工业株式会社 |
用作hdac抑制剂的噁二唑衍生物
|
|
RU2695227C9
(ru)
*
|
2015-07-27 |
2020-03-04 |
Чонг Кун Данг Фармасьютикал Корп. |
Производные 1,3,4-оксадиазолсульфамида в качестве ингибитора гистондеацетилазы 6 и содержащая их фармацевтическая композиция
|
|
NZ739211A
(en)
|
2015-07-27 |
2019-05-31 |
Chong Kun Dang Pharmaceutical Corp |
1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same
|
|
PL3328843T3
(pl)
|
2015-07-27 |
2023-02-27 |
Chong Kun Dang Pharmaceutical Corp. |
Związki będące pochodnymi 1,3,4 oksadiazolosulfonamidów jako inhibitor deacetylazy histonowej 6, oraz kompozycja farmaceutyczna je zawierająca
|
|
PT3331864T
(pt)
|
2015-08-04 |
2022-01-18 |
Chong Kun Dang Pharmaceutical Corp |
Compostos derivados de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica compreendendo os mesmos
|
|
US10406146B2
(en)
|
2015-08-25 |
2019-09-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
CA3001666C
(en)
*
|
2015-10-12 |
2021-03-30 |
Chong Kun Dang Pharmaceutical Corp. |
Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
|
|
WO2017222952A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
US20180016314A1
(en)
|
2016-07-12 |
2018-01-18 |
Children's Hospital Medical Center |
Treatment of disease via transcription factor modulation
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
JP2020520947A
(ja)
|
2017-05-24 |
2020-07-16 |
オーファザイム エー／エス |
熱ショックタンパク質誘導因子および前頭側頭障害
|
|
EP3661931A1
(en)
*
|
2017-07-31 |
2020-06-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
US11458122B2
(en)
|
2017-08-09 |
2022-10-04 |
Children's Hospital Medical Center |
Methods for treating diseases and nerve injuries
|
|
WO2019030692A1
(en)
|
2017-08-10 |
2019-02-14 |
Friedrich Miescher Institute For Biomedical Research |
HDAC6 AND AGGREGATION OF PROTEINS
|
|
JP6910984B2
(ja)
|
2018-03-30 |
2021-07-28 |
株式会社ホンダアクセス |
脱出ハンマー収容具
|
|
KR102316234B1
(ko)
*
|
2018-07-26 |
2021-10-22 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
|
|
HRP20250048T1
(hr)
|
2018-10-22 |
2025-03-28 |
Alumis Inc. |
Inhibitori tyk2 i njihova uporaba
|
|
JP7470058B2
(ja)
|
2019-01-30 |
2024-04-17 |
武田薬品工業株式会社 |
複素環化合物
|
|
AU2020353984B2
(en)
*
|
2019-09-27 |
2025-09-25 |
Takeda Pharmaceutical Company Limited |
2-isoindol-1,3,4-oxadiazole derivatives useful as HDAC6 inhibitors
|